中风球麻合剂联合咽三针治疗脑梗死后吞咽障碍的临床观察

Clinical observation on treating swallowing disorder after cerebral infarction with the Zhongfeng Qiuma decoction plus Yansanzhen acupuncture

目的:观察中风球麻合剂联合咽三针治疗脑梗死后吞咽障碍的临床疗效。方法:将81例急性脑梗死合并吞咽障碍患者随机分为两组,对照组40例采用常规治疗联合电刺激治疗,常规治疗包括阿司匹林抗血小板聚集、阿托伐他汀降脂稳定斑块、依达拉奉清除自由基、丁苯酞注射液保护线粒体,控制血压、血糖等;治疗组41例加用中风球麻合剂及咽三针治疗。一个疗程为14d,每组治疗2个疗程,共计28d。治疗后应用洼田饮水试验评价疗效,藤岛一郎吞咽障碍评分评价吞咽功能。结果:治疗后洼田饮水试验疗效评价显示治疗组总有效率为95.12%,对照组总有效率为80.00%,治疗组优于对照组(P<0.05);藤岛一郎吞咽障碍评分显示两组治疗后吞咽功能较疗前均有改善,且治疗组优于对照组(P<0.05)。结论:中风球麻合剂联合咽三针治疗能够明显改善脑梗死患者吞咽功能,提高生活质量,适合推广应用。

Objective:To observe clinical effects of the Zhongfeng Qiuma decoction plus Yansanzhen acupuncture on swallowing disorder after cerebral infarction.Methods:81cases were randomly divided into two groups.40cases in the control group took conventional western medicine plus electrical stimulation therapy.Conventional western medicine treatment included aspirin to antiplatelet aggregation,atorvastatin to stable plaques,edaravone to scavenge free radicals,butylphthalide injection to protect mitochondria,controlling blood pressure and blood glucose and so on.41cases in the treatment group received the Zhongfeng Qiuma decoction plus Yansanzhen acupuncture therapy more.14days was a period,for2periods.Results:The drinking water test result indicated that the total efficiency in the treatment group was95.12%,better than80.00%in the control group(P<0.05).The Toshima Ichiro swallowing efficiency score assessment result showed that swallowing function in groups were both improved than before treatment;And that in the treatment group is superior than the control group(P<0.05).Conclusion:The Zhongfeng Qiuma decoction with Yansanzhen acupuncture therapy can effectively improve swallowing disorder after cerebral infarction,and enhance life quality,and is suitable for further popularization and application.